Common Stock, Shares, Outstanding of Anika Therapeutics, Inc. from Q4 2010 to Q3 2025

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Anika Therapeutics, Inc. quarterly Common Stock, Shares, Outstanding history and change rate from Q4 2010 to Q3 2025.
  • Anika Therapeutics, Inc. Common Stock, Shares, Outstanding for the quarter ending 30 Sep 2025 was 14.4M shares, a 1.86% decline year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

Anika Therapeutics, Inc. Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed
Q3 2025 14.4M -273K -1.86% 30 Sep 2025 10-Q 05 Nov 2025
Q2 2025 14.4M -421K -2.84% 30 Jun 2025 10-Q 30 Jul 2025
Q1 2025 14.3M -485K -3.27% 31 Mar 2025 10-Q 09 May 2025
Q4 2024 14.4M -244K -1.66% 31 Dec 2024 10-Q 05 Nov 2025
Q3 2024 14.7M +57K +0.39% 30 Sep 2024 10-Q 04 Nov 2024
Q2 2024 14.8M +182K +1.24% 30 Jun 2024 10-Q 08 Aug 2024
Q1 2024 14.8M +80K +0.54% 31 Mar 2024 10-Q 08 May 2024
Q4 2023 14.7M +35K +0.24% 31 Dec 2023 10-K 17 Mar 2025
Q3 2023 14.6M +30K +0.21% 30 Sep 2023 10-Q 03 Nov 2023
Q2 2023 14.7M +59K +0.4% 30 Jun 2023 10-Q 08 Aug 2023
Q1 2023 14.7M +223K +1.54% 31 Mar 2023 10-Q 09 May 2023
Q4 2022 14.6M +184K +1.27% 31 Dec 2022 10-K 15 Mar 2024
Q3 2022 14.6M +171K +1.19% 30 Sep 2022 10-Q 09 Nov 2022
Q2 2022 14.6M +180K +1.25% 30 Jun 2022 10-Q 04 Aug 2022
Q1 2022 14.5M +152K +1.06% 31 Mar 2022 10-Q 06 May 2022
Q4 2021 14.4M +112K +0.78% 31 Dec 2021 10-K 16 Mar 2023
Q3 2021 14.4M +228K +1.61% 30 Sep 2021 10-Q 05 Nov 2021
Q2 2021 14.4M +214K +1.51% 30 Jun 2021 10-Q 06 Aug 2021
Q1 2021 14.4M +168K +1.18% 31 Mar 2021 10-Q 07 May 2021
Q4 2020 14.3M +21K +0.15% 31 Dec 2020 10-K 11 Mar 2022
Q3 2020 14.2M -61K -0.43% 30 Sep 2020 10-Q 05 Nov 2020
Q2 2020 14.2M +419K +3.04% 30 Jun 2020 10-Q 07 Aug 2020
Q1 2020 14.2M -16K -0.11% 31 Mar 2020 10-Q 22 May 2020
Q4 2019 14.3M +98K +0.69% 31 Dec 2019 10-K/A 26 Apr 2021
Q3 2019 14.3M +58K +0.41% 30 Sep 2019 10-Q 28 Oct 2019
Q2 2019 13.8M -799K -5.48% 30 Jun 2019 10-Q 26 Jul 2019
Q1 2019 14.2M -531K -3.6% 31 Mar 2019 10-Q 06 May 2019
Q4 2018 14.2M -478K -3.25% 31 Dec 2018 10-K 06 Mar 2020
Q3 2018 14.2M -451K -3.08% 30 Sep 2018 10-Q 26 Oct 2018
Q2 2018 14.6M -74K -0.51% 30 Jun 2018 10-Q 31 Jul 2018
Q1 2018 14.7M +90K +0.61% 31 Mar 2018 10-Q 10 May 2018
Q4 2017 14.7M +61K +0.42% 31 Dec 2017 10-K 27 Feb 2019
Q3 2017 14.7M +39K +0.27% 30 Sep 2017 10-Q 27 Oct 2017
Q2 2017 14.7M -120K -0.81% 30 Jun 2017 10-Q 28 Jul 2017
Q1 2017 14.7M -113K -0.77% 31 Mar 2017 10-Q 04 May 2017
Q4 2016 14.6M -410K -2.73% 31 Dec 2016 10-K 27 Feb 2018
Q3 2016 14.6M -389K -2.59% 30 Sep 2016 10-Q 01 Nov 2016
Q2 2016 14.8M -226K -1.51% 30 Jun 2016 10-Q 01 Aug 2016
Q1 2016 14.8M -235K -1.57% 31 Mar 2016 10-Q 03 May 2016
Q4 2015 15M +185K +1.25% 31 Dec 2015 10-K 24 Feb 2017
Q3 2015 15M +211K +1.43% 30 Sep 2015 10-Q 03 Nov 2015
Q2 2015 15M +206K +1.39% 30 Jun 2015 10-Q 04 Aug 2015
Q1 2015 15M +383K +2.62% 31 Mar 2015 10-Q 04 May 2015
Q4 2014 14.9M +562K +3.94% 31 Dec 2014 10-K 10 Mar 2016
Q3 2014 14.8M +534K +3.75% 30 Sep 2014 10-Q 06 Nov 2014
Q2 2014 14.8M +781K +5.57% 30 Jun 2014 10-Q 04 Aug 2014
Q1 2014 14.6M +614K +4.38% 31 Mar 2014 10-Q 05 May 2014
Q4 2013 14.3M +423K +3.05% 31 Dec 2013 10-K 13 Mar 2015
Q3 2013 14.3M +461K +3.34% 30 Sep 2013 10-Q 05 Nov 2013
Q2 2013 14M +251K +1.83% 30 Jun 2013 10-Q 06 Aug 2013
Q1 2013 14M +243K +1.77% 31 Mar 2013 10-Q 06 May 2013
Q4 2012 13.9M +235K +1.73% 31 Dec 2012 10-K 13 Mar 2014
Q3 2012 13.8M +183K +1.34% 30 Sep 2012 10-Q 08 Nov 2012
Q2 2012 13.8M +144K +1.06% 30 Jun 2012 10-Q 07 Aug 2012
Q1 2012 13.8M 31 Mar 2012 10-Q 07 May 2012
Q4 2011 13.6M +148K +1.1% 31 Dec 2011 10-K 14 Mar 2013
Q3 2011 13.6M 30 Sep 2011 10-Q 04 Nov 2011
Q2 2011 13.6M 30 Jun 2011 10-Q/A 10 Aug 2011
Q4 2010 13.5M 31 Dec 2010 10-K 13 Mar 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.